VMS NET Login
Type your username and password then click on the appropriate section you wish to access.
Click here if your login fails (might occur on certain Apple products)
About Us
VMS Group covers all aspects of service, such as repair and maintenance, spare parts delivery, sales of complete propulsion systems as well as engineering projects within the maritime industry, the offshore industry, power plants and wind industry.
From 1 January 2017, Vestergaard Marine Service, DT-Interlink and VMS Technology have merged into the parent company VMS Group A/S.
By merging our activities in a more transparent and manageable organisation, our customers get the full benefit of the synergies and strengths that our teams of competent, experienced and knowledgeable staff provide – worldwide. Furthermore, the merger enables us to handle even bigger and more complex jobs from first inspections to the final commissioning.
VMS Group employs approx. 100 industrial technicians, service engineers and supervisors travelling worldwide. Another approx. 20 senior project managers and project managers are responsible for the planning, management and coordination of our projects.
Facts about VMS Group A/S
In addition to VMS Group A/S in Frederikshavn, Denmark, the group consists of VMS do Brasil in Rio de Janeiro, Brazil and Vestergaard Marine Service Namibia in Walvis Bay, Namibia.
VMS Group and affiliated companies employ approx. 250 employees.
Our core services include:
- Repair and maintenance of diesel engines, turbochargers, gear, propellers etc. to the marine industry, the offshore industry, power plants and wind turbines
- Sales of spare parts and engines
- Design, engineering and project management
Approvals
In a retrospective review, doses less than 0. Since this medicine aids in digestion, it can affect how well your body absorbs any other medicines you need to take. Simeprevir: (Moderate) Coadministration of disopyramide with simeprevir, an intestinal CYP3A4 inhibitor, may result in mild increases in disopyramide plasma concentrations www.pharmaciesansordonnance.org. Permanently discontinue ENHERTU in patients with symptomatic congestive heart failure (CHF).
